News Briefs: Injunction Against Medtronic TAVI Begins; Hospitals Spending Growing Faster Than Revenue
This article was originally published in The Gray Sheet
Executive Summary
An injunction against sales in Germany of Medtronic’s CoreValve transcatheter aortic valve products begins. Moody’s reports hospital’s expenses grew faster in 2012 than their revenue, which is unsustainable, according to the ratings company. Volcano buys Medtronic’s Pioneer Plus catheters. Medtronic and Covidien open centers in Asia.
You may also be interested in...
News In Brief
Sales of Medtronic’s CoreValve blocked in Germany. Myriad Genetics sues BRCA test competitors. More news.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.